Research field (4):
Neurology
, Healthcare management, medical sociology
, Biological, health, and medical informatics
, Neurology
Research theme for competitive and other funds (6):
2025 - 2028 アルツハイマー病疾患修飾療法の待機時間短縮に向けたデータサイエンス戦略
2025 - 2028 Clinical Registry Study on Risk Factors for Cerebral Amyloid Angiopathy and Amyloid-Related Imaging Abnormalities (ARIA)
2024 - 2028 Dementia Research Platform
2024 - 2028 特性に基づく非アルツハイマー病の分類と超早期の臨床的特徴の検討
2023 - 2028 DMT Registry
2021 - 2023 Web-based screening of neurological diseases using pose estimator
Show all
Papers (69):
Saki Nakashima, Shotaro Aso, Hideo Yasunaga, Kenichiro Sato, Yoshiki Niimi, Toshiaki Isogai, Hiroki Matsui, Kiyohide Fushimi, Tatsushi Toda, Satoshi Kodama. Effectiveness and safety of prasugrel- versus clopidogrel-based dual antiplatelet therapy for acute ischemic stroke. Journal of the neurological sciences. 2025. 480. 125695-125695
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, Kazushi Suzuki, Atsushi Iwata, Takeshi Iwatsubo. Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theory. Journal of Alzheimer's disease : JAD. 2025. 108. 3. 13872877251385119-13872877251385119
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Kiyotaka Nemoto, Tetsuaki Arai, Shinji Higashi, Ataru Igarashi, Kensaku Kasuga, Haruhiko Akiyama, et al. Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. 21. 10. e70652
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Kazushi Suzuki, Takeshi Iwatsubo. Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2025. 106. 3. 13872877251350718-13872877251350718
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, Saki Nakashima, Atsushi Iwata, Takeshi Iwatsubo. Disparities in out-of-pocket costs for disease-modifying therapy under Japan's universal health insurance system. The journal of prevention of Alzheimer's disease. 2025. 100170-100170
Lower Serum Calcium As a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer’s Disease in Japanese Alzheimer’s Disease Neuroimaging Initiatives
(Alzheimer's Association International Conference (AAIC) 2019)